Lunit announced an abstract presentation of its artificial intelligence (AI) precision medicine research portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting 2019, held May 31 – June 4 in Chicago. The accepted abstract highlights the feasibility of AI-based biomarkers in metastatic non-small cell lung cancer, based on the H&E analysis that predicts response to immune checkpoint inhibitors (ICI).
May 31, 2019 — Intelerad Medical Systems announced a $75 million investment in research and development (R&D) to expand ...
It is not surprising that pressure is mounting for medical providers to improve the care outcomes of their patients ...
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
In recent years there has been a lot of debate about the role of the mammographer with regard to examining the patient’s ...
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the annual ...
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Change is a consistent theme in our world today, no matter where you look. In healthcare, change — while slower than ...
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
As of 2015, approximately 79 million computed tomography (CT) scans were performed each year in the U.S. Of those, 36 ...
In this study, the client was a large enterprise health system serving 1.4 million patients across the United States ...
Much has been made in recent years about the explosion of artificial intelligence (AI) in radiology and how it might ...
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Medical imaging and informatics are critical to delivering care and managing wellness. Imaging was an early adopter of ...
This webinar will explain technical considerations when performing cardiac CT angiography in pediatric patients. It ...
Chest pain is one of the most frequent reasons for an evaluation in the emergency room.There are multiple imaging ...
Did you know that approximately one-third of all the data in world is created by the healthcare industry and that ...
Cleveland Clinic Union Hospital (CCUH) has served the community of Ohio’s Tuscarawas Valley for more than 100 years ...
Computed tomography (CT) has traditionally played an important role in the development of radiation therapy treatment ...
SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
Imaging Technology News (ITN) recently took home top honors for best technical content for its team coverage of the ...
May 29, 2019 — QT Ultrasound recently showcased its advanced ultrasound technology at the Acoustical Society of America ...
A clinical study presented at the American Thoracic Society (ATS) 2019 annual meeting, May 17-22 in Dallas, described the use of Konica Minolta’s Dynamic Digital Radiography (DDR) technology in the assessment of undifferentiated dyspnea.
Out of more than 7 million current and former heavy smokers, only 1.9 percent were screened for lung cancer in 2016 despite screening recommendations, according to a new analysis. These numbers come despite U.S. Preventive Services Task Force (USPSTF) and American Society of Clinical Oncology (ASCO) screening recommendations.
Leica Biosystems has received clearance from the U.S. Food and Drug Administration (FDA) to market its Aperio AT2 DX System for clinical diagnosis in the U.S.
While radiation therapy as a discipline is well into maturity, new technology advances continue to drive the field ...